Skip to main content
The Patent Truth About Health, Innovation and Access
Heer Pardesi, who is 42 years old, holds her antiretroviral drugs for HIV. (Jonas Gratzer/LightRocket via Getty Images)

The Patent Truth About Health, Innovation and Access

Carol Adelman

View PDF

This report reviews and analyzes the following premises of the U.N.‘s High Level Panel on Access to Medicines, which are:

  1. Millions of poor people in low- and middle-income countries have been denied access to antiretroviral drugs and other medicines;
  2. Patents are the main cause of higher costs of medicines for poor people in low- and middle-income countries;
  3. The intellectual property system, including patents and voluntary licenses, limits research and disadvantages local producers in low- and middle- income countries.

These basic assumptions, drawing from the earlier Global Commission on HIV and the Law and the new High Level Panel on Access to Medicines, however, are not supported by global health research.

View PDF

Related Articles

Transcript: Containing the Coronavirus: Challenges to Thwarting the Outbreak

Eric B. Brown et al.

Following is the full transcript of the February 10th, 2020 Hudson event titled Containing the Coronavirus: Challenges to Thwarting the Outbreak...

Continue Reading

China's Communist Party 'Values Loyalty to Party Over Competency'

Rebeccah L. Heinrichs

In an interview with Liz MacDonald on Fox Business, Rebeccah Heinrichs discusses China’s Communist government’s role in the under-reporting of Coronav...

Watch Now

Coronavirus Tests U.S. Medical System's Unhealthy Reliance on China for Drugs and Supplies

Tim Morrison

"Chinese President Xi Jinping()":https://www.washingtonpost.com/world/coronavirus-china-live-updates/2020/01/25/0ca57a5e-3ed7-11ea-afe2-090eb37b60b1_s...

Continue Reading